Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice

• Príomhchruthaitheoirí: Andrey E. Karateev (Údar), Elena Iu. Polishchuk (Údar), Alena S. Potapova (Údar), Elena V. Matyanova (Údar), Ekaterina S. Filatova (Údar), Svetlana I. Glukhova (Údar), Aleksander M. Lila (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: ZAO "Consilium Medicum", 2023-05-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background. Slow-acting symptomatic agents (chondroprotectors) in osteoarthritis (OA) combined therapy is a promising approach. Aim. To compare the real-world results of combined therapy with glycosaminoglycan-peptide complex (GPC) and diacerein with GPC monotherapy in treating knee OA. Materials an...